
Latest Health News
Tetanus Market Projected to Reach USD 2.70 Billion by 2036
The global tetanus market is expected to grow to USD 2.70 billion by 2036, driven by advancements in treatments and global demand. Future Market Insights reports steady growth influenced by improved vaccination and therapeutic options. This projection underscores ongoing efforts to combat tetanus worldwide.
Papillary Thyroid Cancer Market Enters Steady Growth Phase
Latest insights indicate the global papillary thyroid cancer market is experiencing steady growth as of April 17, 2026. Future Market Insights highlights increasing awareness and innovative therapies fueling this expansion. The market's trajectory points to enhanced diagnostic and treatment capabilities.
Word of the Day: Hemophilia - Rare Blood Clotting Disorder
Hemophilia, a rare inherited blood disorder, prevents proper clotting due to deficient proteins or clotting factors. ABS-CBN Lifestyle featured it as the Word of the Day on April 17, 2026, raising awareness about this genetic condition. It affects primarily males and requires lifelong management.
Sitting Disease Warns of Harms from Prolonged Sedentary Behavior
Excessive sitting and lack of exercise pose significant health risks, contributing to various diseases. Dawn.com's article updated on April 17, 2026, emphasizes that both inactivity and too much sitting harm human health. Experts recommend balancing activity to mitigate these effects.
WHO: Lung Cancer Leads Global Cancer Cases and Deaths
Lung cancer caused an estimated 2.5 million new cases and 1.8 million deaths worldwide in 2022, remaining the top cancer killer. The WHO fact sheet stresses prevention through tobacco control and reducing air pollution exposure. Early screening could improve survival rates dramatically.
Advances in Neuroendocrine Tumor Treatments Highlighted at Summit
Dr. David Zhen discussed evolving NET treatments at the 2026 Hawaii Gastrointestinal Cancers Summit, including FDA-approved cabozantinib. Peptide receptor radionuclide therapy (PRRT) shows promise for earlier use, with alpha-emitter therapies in development. Clinical trials are recommended for GEP-NET patients.
Cold Chain Failures Threaten Global Vaccine Delivery
Vaccines require storage between 2°C and 8°C, but cold chain breakdowns increase risks in global health delivery. The New Times article details the high costs and consequences of these failures on immunization programs. Reliable infrastructure is crucial for effective vaccine distribution.
WHO Prioritizes Integrated Lung Health Approach for 2025
The World Health Assembly's 2025 Resolution focuses on lung cancer through tobacco control and early detection. WHO supports reducing environmental carcinogens and improving access to treatments. This aims to lower mortality and advance universal health coverage.
Neuroendocrine Carcinomas See New Treatment Strategies
Aggressive neuroendocrine carcinomas benefit from emerging therapies like next-generation radioligand options. Dr. Zhen's summit update notes reshaping clinical approaches for well-differentiated NETs. Earlier PRRT may outperform other targeted agents.
Lung Cancer Prevention Focuses on Tobacco and Pollution Reduction
Over 60-70% of lung cancer cases link to tobacco, with air pollution and occupational risks following. WHO advocates primary prevention and screening for high-risk groups. These measures could prevent over 1.3 million male and 500,000 female cases.